Changes in the pattern of analgesic opioid drugs consumption in Spain;Cambios en el patron de consumo de analgesicos opioides en Espana

Medicina Clinica

Volumn 109, Issue 8, 1997, Pages 281-283

  Carvajal, Alfonso ^a   Del Pozo, Javier García ^a   Arias, Luis H Martín ^a   De Diego, Isaac Martín ^a   Rueda, Ana Maria ^a   Caro Patón, Tomás ^a   Requejo, Ana Álvarez ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DEXTROPROPOXYPHENE; DIHYDROCODEINE; METHADONE; MORPHINE; PENTAZOCINE; PETHIDINE; TILIDINE; TRAMADOL; CODEINE; DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; DATA BASE; DRUG FORMULATION; DRUG MONITORING; DRUG UTILIZATION; HUMAN; PRESCRIPTION; PREVALENCE; SPAIN; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ANALGESICS, OPIOID; BUPRENORPHINE; CODEINE; DATABASES; HUMANS; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MEPERIDINE; METHADONE; MORPHINE; PENTAZOCINE; PRESCRIPTIONS, DRUG; PROPOXYPHENE; SPAIN; TILIDINE; TRAMADOL;

EID: 0030979699     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Prieto Yerro I, Prieto Yerro C, Sacristán Rodea A. Utilización de analgésicos narcóticos en el tratamiento del dolor, lnf Ter Sist Nac Salud 1991; 15: 180-186.
2. Schug SA, Zech D, Dörr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manag 1990; 5: 27-32.
3. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation of the WHO method for cancer pain relief. Cancer 1987; 59: 850-856.
4. Walker VA, Hoskin PJ, Hanks GW, White ID. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manag 1988; 3: 145-149.
5. Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: a 3-year survey of the german situation. J Pain Symptom Manag 1995; 10: 187-191.
6. Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993; 341: 1.075-1.076.
7. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de Especialidades Farmacéuticas 1994. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos, 1994.
8. Bases de datos de medicamentos de la Dirección General de Farmacia y Productos Sanitarios. Monografías Técnicas. Madrid: Ministerio de Sanidad y Consumo, 1989.
9. Lunde PKM, Baksaas I, Halse M, Halvorsen IK, Strømmes B, Øydvin K. The methodology of drug utilization studies. En; Bergman U, Grimsson A, Wahba AHW, Werterholm B, editores. Studies in drug utilization. Copenague: WHO Regional Office for Europe. 1979; 17-28.
10. Anatomical Therapeutic Chemical (ATC) Classification index. Oslo: WHO Collaborating Centre for Drugs Statistics Methodology, 1996.
11. Laure F, Colleau SM, Brassur L, Cleeland CS. Multicentre study of cancer pain and its treatment in France. Br Med J 1995; 310: 1.034-1.037.
12. Baños JE, Bosch F. Opiophobia and cancer pain. Lancet 1993; 341: 1.474.
13. Orden de 25 de abril de 1994 del Ministerio de Sanidad y Consumo por la que se regulan las recelas y los requisites especiales de prescripción y dispensación de estupefacientes para uso humano. BOE n.o 105, 3 de mayo de 1994; 13.556-13.564.